1 – 5 of 22
- show: 5
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
The Bispecific Tumor Antigen-Conditional 4-1BB x 5T4 Agonist, ALG.APV-527, Mediates Strong T-Cell Activation and Potent Antitumor Activity in Preclinical Studies
(
- Contribution to journal › Article
- 2017
-
Mark
Tumor-directed immunotherapy can generate tumor-specific T cell responses through localized co-stimulation
(
- Contribution to journal › Article
- 2015
-
Mark
The human agonistic CD40 antibody ADC-1013 eradicates bladder tumors and generates T cell dependent tumor immunity.
(
- Contribution to journal › Article
- 2010
-
Mark
Development of a C5AR antagonist for the treatment of reperfusion injury
2010) 8th Joint Conference of the International-Cytokine-Society/International-Society-for-and-Cytokine-Re search In Cytokine 52(1-2). p.26-26(
- Contribution to journal › Published meeting abstract
-
Mark
Directed evolution of chemotaxis inhibitory protein of Staphylococcus aureus generates biologically functional variants with reduced interaction with human antibodies
(
- Contribution to journal › Article